Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for ...
President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...
President Donald Trump's steep tariffs on Canada, Mexico and China could worsen ex­ist­ing drug short­ages in the U.S. and raise healthcare costs for patients, some drug trade groups warn. They also ...